glp-1 obesity drug news today september 15 2025 Alarming rise in weight loss overdoses A network meta-analysis backed weight-loss
Description
Introduction Dementia and Alzheimers disease (AD) have long been framed as primarily neurological disorders, but a growing body of evidence suggests they are deeply intertwined with metabolic, vascular, and inflammatory dysfunction
2024 State Action Late last year, Illinois adopted a bill to cover certain weight loss and obesity medicines, including GLP-1s, under the state employee health plan
[DOI] [PubMed] [Google Scholar] 171
Many users are left to pay for GLP-1 weight loss medications, which can cost more than $1,000 per month, out of pocket
doi: 10.1038/nrgastro.2013.105
